High Dose Heparin as Pretreatment for Primary Angioplasty in Acute Myocardial Infarction: The Heparin in Early Patency (HEAP) Trial - HEAP

Description:

HEAP was an open-label, randomized trial of high dose heparin versus low dose heparin for patients with acute myocardial infarction (AMI) scheduled to undergo primary angioplasty.